PMA eSubmissions, GRAIL Panel, China AI Study Guide, and More
In this week’s Pathways Picks: FDA takes step toward mandatory electronic PMAs; congressional watchdog looks at FDA third party reviewers; an advisory panel support GRAIL’s cancer-screening PMA; FDA commissioner nominee heads to the Hill; China issues guides on AI clinical evaluation, good manufacturing practices, and real world data quality; and more medtech policy updates.